Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × IFL protocol × 30 days × Clear all

Phase

Status

Recruiting 7 Not yet recruiting 2 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Specimen Handling 17 Magnetic Resonance Spectroscopy 10 Biopsy 9 durvalumab 4 Vincristine 4 Cyclophosphamide 4 Nivolumab 3 Lenalidomide 3 Etoposide 3 Doxorubicin 3 Dexamethasone 3 Cisplatin 3 Carboplatin 3 venetoclax 2 trastuzumab deruxtecan 2 prednylidene 2 pembrolizumab 2 deltacortene 2 decitabine and cedazuridine drug combination 2 X-Rays 2 Temozolomide 2 Rituximab 2 Radiotherapy 2 Radiation 2 Prednisone 2 Platinum 2 Ipilimumab 2 Educational Status 2 CTLA-4 Antigen 2 Actinium 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05419479 2026-02-24

Switch Maintenance in Pancreatic

Dana-Farber Cancer Institute

Phase 1/2 Suspended

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡